The right pediatric program to deliver your medicine sooner
Providing new treatments for children requires careful planning and expertise. Successfully navigating this road requires a specialized mix of scientific, therapeutic, regulatory and operational expertise to ensure your pediatric studies are successfully planned and executed – with patient safety at the center of everything you do.
From the earliest planning stages of clinical development, through launch and real-world assessment, pediatric expertise is key to ensuring you are asking the right questions to meet the specific needs of infants, children and adolescents.
IQVIA’s deep domain expertise in pediatric research combined with our access to patient data, study site networks and knowledgeable in-house regulatory experts, makes us a leader in pediatric drug development. From start to finish, we can help you:
- Develop your product’s Pediatric Investigational Plan and/or Pediatric Study Plan
- Conceptualize and conduct pediatric clinical studies
- Connect you to a network of specialized pediatric study sites
- Identify, consent and retain pediatric patients and their families throughout your program
Pediatric Investigational Plans and Pediatric Study Plans
In an effort to expand the availability of medicines to children, the FDA and EMA require evidence of planning for pediatric safety and efficacy data at an early stage in all drug development programs. , Proactively developing Pediatric Investigational Plans and Pediatric Study plans can save valuable time and expense. See how IQVIA’s experts can support you.
Pediatric Center of Excellence
Experts from across IQVIA come together to help you conceptualize and execute your pediatric studies. The group is charged with advising on the conduct of pediatric programs to ensure the right strategy and the right level of oversight, counsel, training and collaboration is applied to your project
Identify the right path to fulfill pediatric safety requirements and deliver a product that meets the unique needs of infants, children and adolescents, from trial environments into their everyday lives.
By: Claude Hughes